| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of the end-tidal CO2 measured by portable capnometer and the arterial P CO2 in spontaneously breathing patients
|
TAKANO, Y.
|
|
2003
|
97 |
5 |
p. 476-481
6 p.
|
artikel
|
| 2 |
Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma
|
IND, P.W.
|
|
2003
|
97 |
5 |
p. 555-562
8 p.
|
artikel
|
| 3 |
Apparent primary pleural melanoma: case report and literature review
|
UM, S.W.
|
|
2003
|
97 |
5 |
p. 586-587
2 p.
|
artikel
|
| 4 |
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD
|
CAZZOLA, M.
|
|
2003
|
97 |
5 |
p. 458-462
5 p.
|
artikel
|
| 5 |
Breathing retraining for asthma
|
RAM, F.S.F.
|
|
2003
|
97 |
5 |
p. 501-507
7 p.
|
artikel
|
| 6 |
Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD
|
CAZZOLA, M.
|
|
2003
|
97 |
5 |
p. 453-457
5 p.
|
artikel
|
| 7 |
Corrigendum to: “Effects by 8-bromo-cyclicAMP on basal and organic dust-induced release of inteleukin-6 and -8 in A549 human airway epithelial cells” Respir Med 2003; 97 (1): 46–50
|
BURVALL, K.
|
|
2003
|
97 |
5 |
p. 588-
1 p.
|
artikel
|
| 8 |
Effects of oral montelukast on airway function in acute asthma
|
ÇÝLLÝ, A
|
|
2003
|
97 |
5 |
p. 533-536
4 p.
|
artikel
|
| 9 |
Expression of matrix metalloproteinases MMP-9 within the airways in asthma
|
HAN, Z.
|
|
2003
|
97 |
5 |
p. 563-567
5 p.
|
artikel
|
| 10 |
Fifty μg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FP
|
GIANNINI, D.
|
|
2003
|
97 |
5 |
p. 463-467
5 p.
|
artikel
|
| 11 |
Gender differences in asthma prevalence may depend on how asthma is defined
|
HENRIKSEN, A.H.
|
|
2003
|
97 |
5 |
p. 491-497
7 p.
|
artikel
|
| 12 |
Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis
|
MIKI, K.
|
|
2003
|
97 |
5 |
p. 482-490
9 p.
|
artikel
|
| 13 |
Interleukin-18 expression in BAL cells of sarcoidosis patients is decreased in vivo but protein secretion is not impaired in vitro
|
HAUBER, H.-P.
|
|
2003
|
97 |
5 |
p. 521-527
7 p.
|
artikel
|
| 14 |
Low-dose methotrexate for advanced pulmonary disease in patients with cystic fibrosis
|
BALLMANN, M.
|
|
2003
|
97 |
5 |
p. 498-500
3 p.
|
artikel
|
| 15 |
Measuring costs and consequences in economic evaluation in asthma
|
SCULPHER, M.J.
|
|
2003
|
97 |
5 |
p. 508-520
13 p.
|
artikel
|
| 16 |
Overnight home oximetry: can it identify patients with obstructive sleep apnea–hypopnea who have minimal daytime sleepiness?
|
HUSSAIN, S.F.
|
|
2003
|
97 |
5 |
p. 537-540
4 p.
|
artikel
|
| 17 |
Potential utility of BCG test in excluding tuberculosis in adults
|
MATHUR, M.L.
|
|
2003
|
97 |
5 |
p. 528-532
5 p.
|
artikel
|
| 18 |
Relationship of asthma to irritant gas exposures in pulp and paper mills
|
GLINDMEYER, H.W.
|
|
2003
|
97 |
5 |
p. 541-548
8 p.
|
artikel
|
| 19 |
Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma
|
TAUBE, C
|
|
2003
|
97 |
5 |
p. 568-577
10 p.
|
artikel
|
| 20 |
Scintigraphic diagnosis of a right to left shunt in end-stage lung disease
|
GRAVES, M.W.
|
|
2003
|
97 |
5 |
p. 549-554
6 p.
|
artikel
|
| 21 |
The influence of co-morbidity on health-related quality of life in asthma and COPD patients
|
WIJNHOVEN, H.A.H.
|
|
2003
|
97 |
5 |
p. 468-475
8 p.
|
artikel
|
| 22 |
The use of inhaled corticosteroids in the United Kingdom and the Netherlands
|
VAN STAA, T.P
|
|
2003
|
97 |
5 |
p. 578-585
8 p.
|
artikel
|
Tijdschrift beschrijving